Avaliação dos fatores de risco no linfedema pós-tratamento de câncer de mama
Risk factors for breast cancer related lymphedema
Laura Ferreira de Rezende; Alessandra Vilanova Reis Rocha; Caroline Silvestre Gomes
Resumo
Palavras-chave
Abstract
Keywords
Referências
The diagnosis and treatment of peripheral lymphedema: Consensus document of the International Society of Lymphology. Lymphology. 2003;36:84-91.
Soran A, D'angelo G, Begovic M. Breast cancer-related lymphedema: what are the significant predictors and how they affect the severity of lymphdema?. Breast J.. 2006;12:536-43.
Szuba A, Shin WS, Strauss W, Rockson S. The third circulation: radionuclide lymphoscintigraphy in the evaluation of lymphedema. J Nucl Med.. 2003;44:43-57.
Petrek JA, Heelan MC. Incidence of breast carcinoma-related lymphedema. Cancer.. 1998;83(^s12):2776-81.
McCredie MR, Dite GS, Porter L. Prevalence of self-reported arm morbidity following treatment for breast cancer in the Australian Breast Cancer Family Study. Breast.. 2001;10:515-22.
Duff M, Hill AD, McGreal G, Walsh S, McDermott EW, O'Higgins NJ. Prospective evaluation of the morbidity of axillary clearance for breast cancer. Br J Surg.. 2001;88:114-7.
Kwan W, Jackson J, Weir LM, Dingee C, McGregor G, Olivotto IA. Chronic arm morbidity after curative breast cancer treatment: prevalence and impact on quality of life. J Clin Oncol.. 2002;20:4242-8.
Bergmann A, Mattos IE, Koifman RJ. Diagnótico do linfedema: análise dos métodos empregados na avaliação do membro superior após linfadenectomia axilar para tratamento do câncer de mama. Rev Bras Cancerol.. 2004;50:311-20.
Warren AG, Brorson H, Borud LJ, Slavin SA. Lymphedema: a comprehensive review. Ann Plast Surg.. 2007;59:464-72.
Rezende LF, Pedras FV, Ramos CD, Gurgel MSC. Avaliação das compensações linfáticas no pós-operatório de câncer de mama com dissecção axilar através da linfocintilografia. J Vasc Bras.. 2008;7:370-5.
Brennan MJ, DePompolo RW, Garden FH. Focused review: postmastectomy lymphedema. Arch Phys Med Rehabil.. 1996;77(^s3):S74-80.
Bernas MJ, Witte CL, Witte MH. International Society of Lymphology Executive Committee: The diagnosis and treatment of peripheral lymphedema: draft revision of the 1995 Consensus Document of the International Society of Lymphology Executive Committee for discussion at the September 3-7, 2001. 2001;34:84-91.
Camargo M, Marx A. Reabilitação física no câncer de mama. 2000.
Burt J, White G. Lymphedema: a breast cancer patient's guide to prevention and healing. 1999:2-23.
Aboul-Enein A, Eshmawy I, Arafa S, Abboud A. The role of lymphovenous communication in the development of postmastectomy lymphedema. Surgery. 1984;95:562-6.
Herd-Smith A, Russo A, Muraca MG, Del Turco MR, Cardona G. Cancer.. 2001;92:1783-7.
Hayes SC, Janda M, Cornish B, Battistutta D, Newman B. Lymphedema after breast cancer: incidence, risk factors, and effect on upper body function. J Clin Oncol.. 2008;26:3536-42.
Pain SJ, Vowler S, Purushotham AD. Axillary vein abnormalities contribute to development of lymphoedema after surgery for breast cancer. Br J Surgery.. 2005;92:311-15.
Johansson K, Ohlsson K, Ingvar C, Albertsson M, Ekdahl C. Factors associated with the development of arm lymphedema following breast cancer treatment: a match pair case-control study. Lymphology. ;2002(35):59-71.
Ozaslan C, Kuru B. Lymphedema after treatment of breast cancer. Am J Surg.. 2004;187:69-72.
Erickson VS, Pearson ML, Ganz PA, Adams J, Kahn KL. J Natl Cancer Inst.. 2001;93:96-111.
Purushotham AD, Bennett Britton TM, Klevesath MB, Chou P, Agbaje OF, Duffy SW. Lymph node status and breast cancer-related lymphedema. Ann Surg.. 2007;246(42-45).
Meeske KA, Sullivan-Halley J, Smith AW, McTiernan A, Baumgartner KB, Harlan LC. Risk factors for arm lymphedema following breast cancer diagnosis in Black women and White women. Breast Cancer Res Treat.. 2009;113:383-91.
Rett MT, Lopes MCA. Fatores de risco relacionados ao linfedema. Rev Bras Mastologia.. 2002;12:39-42.
Park JH, Lee WH, Chung HS. Incidence and risk factors of breast cancer lymphoedema. J Clin Nurs.. 2008;17:1450-59.
Nielsen I, Gordon S, Selby A. Breast cancer-related lymphoedema risk reduction advice: a challenge for health professionals. Cancer Treat Rev.. 2008;34:621-8.
Ellis S. Structure and function of the lymphatic system: an overview. The Lymphoedema Supplement. Br J Community Nurs.. 2006;11(^s4):S4-S6.
Petrek JA, RT Senie, Peters M, Rosen PP. Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer. 2001;92:1368-77.
Pain SJ, Purushotham AD, Barber RW, Ballinger JR, Solanki CK, Mortimer PS. Variation in lymphatic function may predispose to development of breast cancer-related lymphoedema. Eur J Surg Oncol.. 2004;30:508-14.
Bergmann A, Mattos IE, Kofman RJ. Fatores de risco para linfedema após câncer de mama: uma revisão da literatura. Fisioter pesqui.. 2008;15:207-13.
Freitas Jr R, Ribeiro LFJ, Taia L, Kajita D, Fernandes MV, Queiroz GS. Linfedema em pacientes submetidos à mastectomia radical modificada. Rev Bras Ginecol Obstet.. 2001;23:205-8.
Guedes Neto HJ, Kupsinskas Junior AJ, Stuart S, Barbosa EM, Bacarat FF. Cir Vasc Angiol.. ;1995:107-10.
Campisi C, Michelini S, Boccardo F. Guidelines of the Societá Italiana di Linfangiologia. Lymphology. 2004;37:182-4.